1496 related articles for article (PubMed ID: 25283627)
1. Mechanisms underlying social inequality in post-menopausal breast cancer.
Hvidtfeldt UA
Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
[TBL] [Abstract][Full Text] [Related]
2. Risk of breast cancer in relation to combined effects of hormone therapy, body mass index, and alcohol use, by hormone-receptor status.
Hvidtfeldt UA; Tjønneland A; Keiding N; Lange T; Andersen I; Sørensen TI; Prescott E; Hansen ÅM; Grønbæk M; Bojesen SE; Diderichsen F; Rod NH
Epidemiology; 2015 May; 26(3):353-61. PubMed ID: 25695354
[TBL] [Abstract][Full Text] [Related]
3. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia.
Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ
Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278
[TBL] [Abstract][Full Text] [Related]
4. Hormone therapy and breast cancer: what factors modify the association?
Gertig DM; Fletcher AS; English DR; Macinnis RJ; Hopper JL; Giles GG
Menopause; 2006; 13(2):178-84. PubMed ID: 16645531
[TBL] [Abstract][Full Text] [Related]
5. Cohort profile: the Social Inequality in Cancer (SIC) cohort study.
Nordahl H; Hvidtfeldt UA; Diderichsen F; Rod NH; Osler M; Frederiksen BL; Prescott E; Tjønneland A; Lange T; Keiding N; Andersen PK; Andersen I
Int J Epidemiol; 2014 Dec; 43(6):1750-8. PubMed ID: 24550248
[TBL] [Abstract][Full Text] [Related]
6. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
[TBL] [Abstract][Full Text] [Related]
7. Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer.
Modugno F; Kip KE; Cochrane B; Kuller L; Klug TL; Rohan TE; Chlebowski RT; Lasser N; Stefanick ML
Int J Cancer; 2006 Mar; 118(5):1292-301. PubMed ID: 16161054
[TBL] [Abstract][Full Text] [Related]
8. Up to one-third of breast cancer cases in post-menopausal Mediterranean women might be avoided by modifying lifestyle habits: the EPIC Italy study.
Masala G; Bendinelli B; Assedi M; Occhini D; Zanna I; Sieri S; Agnoli C; Sacerdote C; Ricceri F; Mattiello A; Panico S; Tumino R; Frasca G; Saieva C; Palli D
Breast Cancer Res Treat; 2017 Jan; 161(2):311-320. PubMed ID: 27832394
[TBL] [Abstract][Full Text] [Related]
9. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States).
Li CI; Malone KE; Daling JR
Cancer Causes Control; 2006 Jun; 17(5):695-703. PubMed ID: 16633917
[TBL] [Abstract][Full Text] [Related]
10. Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors.
Wasserman L; Flatt SW; Natarajan L; Laughlin G; Matusalem M; Faerber S; Rock CL; Barrett-Connor E; Pierce JP
Int J Obes Relat Metab Disord; 2004 Jan; 28(1):49-56. PubMed ID: 14557830
[TBL] [Abstract][Full Text] [Related]
11. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
[TBL] [Abstract][Full Text] [Related]
13. Alcohol consumption and breast cancer risk in the Women's Health Study.
Zhang SM; Lee IM; Manson JE; Cook NR; Willett WC; Buring JE
Am J Epidemiol; 2007 Mar; 165(6):667-76. PubMed ID: 17204515
[TBL] [Abstract][Full Text] [Related]
14. Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer.
Hvidtfeldt UA; Gunter MJ; Lange T; Chlebowski RT; Lane D; Farhat GN; Freiberg MS; Keiding N; Lee JS; Prentice R; Tjønneland A; Vitolins MZ; Wassertheil-Smoller S; Strickler HD; Rod NH
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1203-12. PubMed ID: 22564867
[TBL] [Abstract][Full Text] [Related]
15. Influence of metabolic indicators, smoking, alcohol and socioeconomic position on mortality after breast cancer.
Larsen SB; Kroman N; Ibfelt EH; Christensen J; Tjønneland A; Dalton SO
Acta Oncol; 2015 May; 54(5):780-8. PubMed ID: 25761087
[TBL] [Abstract][Full Text] [Related]
16. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
17. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
18. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
19. Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer.
Tamimi RM; Spiegelman D; Smith-Warner SA; Wang M; Pazaris M; Willett WC; Eliassen AH; Hunter DJ
Am J Epidemiol; 2016 Dec; 184(12):884-893. PubMed ID: 27923781
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
